Alzprotect`s Phase 2a Study Yields Supportive Results for PSP
18 Sep 2024 //
BUSINESSWIRE
Positive Feedback From the EMA and FDA on Alzprotect`s Phase 2b/3 Development
13 Mar 2024 //
BUSINESSWIRE
18 Sep 2024 //
BUSINESSWIRE
13 Mar 2024 //
BUSINESSWIRE